<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nodgo</journal-id><journal-title-group><journal-title xml:lang="ru">Российский журнал детской гематологии и онкологии (РЖДГиО)</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Pediatric Hematology and Oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2311-1267</issn><issn pub-type="epub">2413-5496</issn><publisher><publisher-name>LTD “Graphica”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21682/2311-1267-2019-6-1-61-66</article-id><article-id custom-type="elpub" pub-id-type="custom">nodgo-473</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASES</subject></subj-group></article-categories><title-group><article-title>Клинический случай излечения генерализованной аденовирусной инфекции на фоне реакции «трансплантат против хозяина» у ребенка после трансплантации костного мозга от гаплоидентичного донора</article-title><trans-title-group xml:lang="en"><trans-title>Clinical case of curing a generalized adenovirus infection on the background of graft versus host reaction in a child after bone marrow transplantation from a haploidentical donor</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3211-6158</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мезенцева</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mezentseva</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-гематолог отделения трансплантации костного мозга</p></bio><bio xml:lang="en"><p>Hematologist Department of Bone Marrow Transplantation</p></bio><email xlink:type="simple">mezentseva_a_v@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4431-1444</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скоробогатова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Skorobogatova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., заведующая отделением трансплантации костного мозга</p></bio><bio xml:lang="en"><p>Dr. of Sci. (Med.), Head of Bone Marrow Transplantation Department</p></bio><email xlink:type="simple">skorobog.e@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4170-7152</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Буря</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Burya</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-гематолог отделения трансплантации костного мозга</p></bio><bio xml:lang="en"><p>Hematologist Department of Bone Marrow Transplantation</p></bio><email xlink:type="simple">burya.a.e@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2945-284X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Киргизов</surname><given-names>К. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kirgizov</surname><given-names>K. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., заместитель директора Института управления и трансляционной медицины НМИЦ ДГОИ им. Дмитрия Рогачева</p></bio><bio xml:lang="en"><p>Cand. of Sci. (Med.), Deputy Director of the Institute of Management and Translational Medicine Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia</p></bio><email xlink:type="simple">kirgiz-off@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2652-8642</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Константинова</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Konstantinova</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-гематолог отделения трансплантации костного мозга</p></bio><bio xml:lang="en"><p>Hematologist Department of Bone Marrow Transplantation</p></bio><email xlink:type="simple">veronika_md@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2395-4045</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мачнева</surname><given-names>Е. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Machneva</surname><given-names>E. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., врач-гематолог отделения трансплантации костного мозга</p></bio><bio xml:lang="en"><p>Cand. of Sci. (Med.), Hematologist Department of Bone Marrow Transplantation</p></bio><email xlink:type="simple">lena.machneva@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4569-657X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пристанскова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pristanskova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>заведующая отделением гематологии и химиотерапии № 1</p></bio><bio xml:lang="en"><p>Head of the Department of Hematology and Chemotherapy № 1</p></bio><email xlink:type="simple">eprist82@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российская детская клиническая больница ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Children’s Clinical Hospital of the N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Российская детская клиническая больница ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России;&#13;
ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Children’s Clinical Hospital of the N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia;&#13;
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>11</day><month>02</month><year>2019</year></pub-date><volume>6</volume><issue>1</issue><fpage>61</fpage><lpage>66</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мезенцева А.В., Скоробогатова Е.В., Буря А.Е., Киргизов К.И., Константинова В.В., Мачнева Е.Б., Пристанскова Е.А., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Мезенцева А.В., Скоробогатова Е.В., Буря А.Е., Киргизов К.И., Константинова В.В., Мачнева Е.Б., Пристанскова Е.А.</copyright-holder><copyright-holder xml:lang="en">Mezentseva A.V., Skorobogatova E.V., Burya A.E., Kirgizov K.I., Konstantinova V.V., Machneva E.B., Pristanskova E.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nodgo.org/jour/article/view/473">https://journal.nodgo.org/jour/article/view/473</self-uri><abstract><p>Аденовирусная инфекция является одной из причин трансплантационно-ассоциированной смертности после аллогенной трансплантации гемопоэтических стволовых клеток. Фульминантная печеночная недостаточность при аденовирусной инфекции представляет диагностическую и терапевтическую проблему в связи с ее агрессивным клиническим течением и крайне неблагоприятным прогнозом, при этом современные методы терапии аденовирусной инфекции основаны на использовании виростатических препаратов и вирус-специфичных лимфоцитов и ассоциированы с тяжелыми побочными эффектами. В статье представлен редкий клинический случай элиминации диссеминированной аденовирусной инфекции с фульминантно развивающейся печеночной недостаточностью у пациента после аллогенной трансплантации костного мозга от гаплоидентичного донора.</p></abstract><trans-abstract xml:lang="en"><p>Adenovirus infection is one of the causes of transplant-associated mortality after allogeneic hematopoietic stem cell transplantation. Fulminant liver failure with adenovirus infection is a diagnostic and therapeutic problem due to its aggressive clinical course and extremely poor prognosis, while modern methods of treating adenovirus infection are based on the use of virostatic drugs and virus-specific lymphocytes and are associated with severe side effects. The article presents a rare clinical case of elimination of disseminated adenoviral infection with fulminantly developing liver failure in a patient after allogeneic bone marrow transplantation from a haploidentical donor.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>аденовирус</kwd><kwd>фульминантный гепатит</kwd><kwd>аллогенная трансплантация костного мозга</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>adenovirus</kwd><kwd>fulminant hepatitis</kwd><kwd>allogeneic bone marrow transplantation</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование проведено без спонсорской поддержки.</funding-statement><funding-statement xml:lang="en">The study was performed without external funding.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Runde1 V., Ross S., Trenschel R., Lagemann E., Basu O., Renzing-Kohler K., Schaefer U.W., Roggendorf M., Holler E. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 2001;28(1):51–7. doi: 10.1038/sj.bmt.1703083.</mixed-citation><mixed-citation xml:lang="en">Runde1 V., Ross S., Trenschel R., Lagemann E., Basu O., Renzing-Kohler K., Schaefer U.W., Roggendorf M., Holler E. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 2001;28(1):51–7. doi: 10.1038/sj.bmt.1703083.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Feghoul L., Chevret S., Cuinet A., Dalle J.H., Ouachée M., Yacouben K., Fahd M., Guérin-El Khourouj V., Roupret-Serzec J., Sterkers G., Baruchel A., Simon F., LeGoﬀJ. Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment. Clin Microbiol Infect 2015;21(7):701–9. doi: 10.1016/j.cmi.2015.03.011.</mixed-citation><mixed-citation xml:lang="en">Feghoul L., Chevret S., Cuinet A., Dalle J.H., Ouachée M., Yacouben K., Fahd M., Guérin-El Khourouj V., Roupret-Serzec J., Sterkers G., Baruchel A., Simon F., LeGoﬀJ. Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment. Clin Microbiol Infect 2015;21(7):701–9. doi: 10.1016/j.cmi.2015.03.011.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Baldwin A., Kingman H., Darville M. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant 2000;26(12):1333–8. doi: 10.1038/sj.bmt.1702716.</mixed-citation><mixed-citation xml:lang="en">Baldwin A., Kingman H., Darville M. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant 2000;26(12):1333–8. doi: 10.1038/sj.bmt.1702716.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ison M.G., Hayden R.T. Adenovirus. In: Diagnostic microbiology of the immunocompromised host. ASM press, 2009. Pp. 129–140.</mixed-citation><mixed-citation xml:lang="en">Ison M.G., Hayden R.T. Adenovirus. In: Diagnostic microbiology of the immunocompromised host. ASM press, 2009. Pp. 129–140.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Van Tol M.J.D., Kroes A.C.M., Schinkel J., Dinkelaar W., Claass E.C.J., Jol-van der Zidje C.M., Vossen J.M. Adenovirus infection in paediatic stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant 2005;36(1):39–50. doi: 10.1038/sj.bmt.1705003.</mixed-citation><mixed-citation xml:lang="en">Van Tol M.J.D., Kroes A.C.M., Schinkel J., Dinkelaar W., Claass E.C.J., Jol-van der Zidje C.M., Vossen J.M. Adenovirus infection in paediatic stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant 2005;36(1):39–50. doi: 10.1038/sj.bmt.1705003.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wy Ip W., Qasim W. Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation. Adv Hematol 2013;2013:176418. doi: 10.1155/2013/176418.</mixed-citation><mixed-citation xml:lang="en">Wy Ip W., Qasim W. Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation. Adv Hematol 2013;2013:176418. doi: 10.1155/2013/176418.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Flomenberg P., Babbitt J., Drobyski W.R., Ash R.C., Carrigan D.R., Sedmak G.V., McAuliﬀe T., Camitta B., Horowitz M.M., Bunin N. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994;169(4): 775–81. PMID: 8133091.</mixed-citation><mixed-citation xml:lang="en">Flomenberg P., Babbitt J., Drobyski W.R., Ash R.C., Carrigan D.R., Sedmak G.V., McAuliﬀe T., Camitta B., Horowitz M.M., Bunin N. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994;169(4): 775–81. PMID: 8133091.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hale G.A., Heslop H.E., Krance R.A., Brenner M.A., Jayawardene D., Srivastava D.K., Patrick C.C. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 1999;23(3):277–82. doi: 10.1038/sj.bmt.1701563.</mixed-citation><mixed-citation xml:lang="en">Hale G.A., Heslop H.E., Krance R.A., Brenner M.A., Jayawardene D., Srivastava D.K., Patrick C.C. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 1999;23(3):277–82. doi: 10.1038/sj.bmt.1701563.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lion T., Baumgartinger R., Watzinger F., Matthes-Martin S., Suda M., Preuner S., Futterknecht B., Lawitschka A., Peters C., Potschger U., Gadner H. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 2003;102(3):1114–20. doi: 10.1182/blood-2002-07-2152.</mixed-citation><mixed-citation xml:lang="en">Lion T., Baumgartinger R., Watzinger F., Matthes-Martin S., Suda M., Preuner S., Futterknecht B., Lawitschka A., Peters C., Potschger U., Gadner H. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 2003;102(3):1114–20. doi: 10.1182/blood-2002-07-2152.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nakazawa H., Ito T., Makishima H., Misawa N., Okiyama W., Uehara T., Hidaka E., Kiyosawa K., Ishida F. Adenovirus fulminant hepatic failure: disseminated adenovirus disease after unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia. Intern Med 2006;45(16):975–80. PMID: 16974062.</mixed-citation><mixed-citation xml:lang="en">Nakazawa H., Ito T., Makishima H., Misawa N., Okiyama W., Uehara T., Hidaka E., Kiyosawa K., Ishida F. Adenovirus fulminant hepatic failure: disseminated adenovirus disease after unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia. Intern Med 2006;45(16):975–80. PMID: 16974062.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kiwan P., Kamel R.R., Kamel R., Hamod D.A. Adenoviral hepatitis in an immunocompetent child: case report. J Pediatr Neonatal Care 2017;7(3):00290. doi: 10.15406/jpnc.2017.07.00290.</mixed-citation><mixed-citation xml:lang="en">Kiwan P., Kamel R.R., Kamel R., Hamod D.A. Adenoviral hepatitis in an immunocompetent child: case report. J Pediatr Neonatal Care 2017;7(3):00290. doi: 10.15406/jpnc.2017.07.00290.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Fowler C.J., Dunlap J., Troyer D., Stenzel P., Epner E., Maziarz R. Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients. Adv Hematol 2010;2010:601548. doi: 10.1155/2010/601548.</mixed-citation><mixed-citation xml:lang="en">Fowler C.J., Dunlap J., Troyer D., Stenzel P., Epner E., Maziarz R. Life-threatening adenovirus infections in the setting of the immunocompromised allogeneic stem cell transplant patients. Adv Hematol 2010;2010:601548. doi: 10.1155/2010/601548.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Neofytos D., Ojha A., Mookerjee B.,Wagner J., Filicko J., Ferber A., Dessain S., Grosso D., Brunner J., Flomenberg N., Flomenberg F. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant 2007;13(1):74–81. doi: 10.1016/j.bbmt.2006.08.040.</mixed-citation><mixed-citation xml:lang="en">Neofytos D., Ojha A., Mookerjee B.,Wagner J., Filicko J., Ferber A., Dessain S., Grosso D., Brunner J., Flomenberg N., Flomenberg F. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant 2007;13(1):74–81. doi: 10.1016/j.bbmt.2006.08.040.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kampmann B., Cubitt D., Walls T., Naik P., Depala M., Samarasinghe S., Robson D., Hassan A., Rao K., Gaspar H., Davies G., Jones A., Cale C., Gilmour K., Real M., Foo M., Bennett-Rees N., Hewitt A., Amrolia P., Veys P. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 2005;130(4):595–603.</mixed-citation><mixed-citation xml:lang="en">Kampmann B., Cubitt D., Walls T., Naik P., Depala M., Samarasinghe S., Robson D., Hassan A., Rao K., Gaspar H., Davies G., Jones A., Cale C., Gilmour K., Real M., Foo M., Bennett-Rees N., Hewitt A., Amrolia P., Veys P. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 2005;130(4):595–603.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">doi: 10.1111/j.1365-2141.2005.05649.x.</mixed-citation><mixed-citation xml:lang="en">doi: 10.1111/j.1365-2141.2005.05649.x.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
